Patents Assigned to Estrogen Vascular Technology, LLC
  • Publication number: 20040127475
    Abstract: A method of treating or preventing high-risk plaque is provided. The method may include applying to a medical device an effective amount of a composition comprising a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator (SERM), or a combination thereof. The medical device may be inserted into an area of a living organism that is or has a propensity to be affected by high-risk plaque.
    Type: Application
    Filed: September 12, 2003
    Publication date: July 1, 2004
    Applicant: Estrogen Vascular Technology, LLC
    Inventors: Gishel New, Jeffrey W. Moses, Nicholas Kipshidze, Gary S. Roubin, Martin B. Leon
  • Publication number: 20030039677
    Abstract: A method of treating or preventing vascular disease in a living organism. The method includes delivering an effective amount of a composition including a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator (SERM), or a combination thereof, to an affected area of a living organism.
    Type: Application
    Filed: September 30, 2002
    Publication date: February 27, 2003
    Applicant: ESTROGEN VASCULAR TECHNOLOGY, LLC.
    Inventors: Gishel New, Jeffrey W. Moses, Nicholas Kipshidze, Gary S. Roubin, Martin B. Leon
  • Patent number: 6471979
    Abstract: A method of treating or preventing vascular disease in a living organism. The method includes delivering an effective amount of a composition including a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator (SERM), or a combination thereof, to an affected area of a living organism.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: October 29, 2002
    Assignee: Estrogen Vascular Technology, LLC
    Inventors: Gishel New, Jeffrey W. Moses, Nicholas Kipshidze, Gary S. Roubin, Martin B. Leon